2.000
−4,76%
2026-10-19
Fundamental Analysis
39 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -135.0% | +124.2% | 1 / 3 | -25.6% | +0.60 pp | -0.54 pp | +3.8% | 1.21 | 4.21 | 432 | −25,6% | −1,1 | −171,3% | 4.21 | 4.61 | −8,7% |
| Pts | 0 | 12 | 4 | 0 | 8 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 2.000 (close price on 2026-10-19)EPS (TTM): 475,4
Financial charts
1.Revenue & growth
VND bn432Q2/26
1.Revenue & growth
VND bn432Q2/26
2.Profit & growth
VND bn-0,58Q2/26
3.Profit mix (Penman)
VND bn16,1Q2/26
4.Margins & cost structure
%3.2%Q2/26
5.Returns & cash cycle
% · days2.4%Q2/26
6.Earnings quality & cash
VND bn155Q2/26
7.Asset structure
VND bn1.170Q2/26
8.Funding & debt health
VND bn · times1.170Q2/26
9.Revenue backlog
VND bn3,98Q2/26
10.Valuation
times · %4,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-21Q2/26
Adjusted EPS growth, latest quarter
-125%
Average adjusted EPS growth, 3 quarters
128%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26